BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20149568)

  • 1. Simultaneous HPLC determination of tolbutamide, phenacetin and their metabolites as markers of cytochromes 1A2 and 2C6/11 in rat liver perfusate.
    Jurica J; Konecný J; Zahradníková LZ; Tomandl J
    J Pharm Biomed Anal; 2010 Aug; 52(4):557-64. PubMed ID: 20149568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
    Zhang S; Song N; Li Q; Fan H; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):78-89. PubMed ID: 18614408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a simple LC method for the determination of phenacetin, coumarin, tolbutamide, chlorzoxazone, testosterone and their metabolites as markers of cytochromes 1A2, 2A6, 2C11, 2E1 and 3A2 in rat microsomal medium.
    Zhai X; Lu Y
    Pharmazie; 2013 Jan; 68(1):19-26. PubMed ID: 23444776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPLC determination of midazolam and its three hydroxy metabolites in perfusion medium and plasma from rats.
    Jurica J; Dostálek M; Konecný J; Glatz Z; Hadasová E; Tomandl J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):571-7. PubMed ID: 17350905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vitexin on the pharmacokinetics and mRNA expression of CYP isozymes in rats.
    Wang XS; Hu XC; Chen GL; Yuan X; Yang RN; Liang S; Ren J; Sun JC; Kong GQ; Gao SG; Feng XS
    Phytother Res; 2015 Mar; 29(3):366-72. PubMed ID: 25447838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the activity of P450 enzymes in rats: use of the single marker or combined drug administration.
    Jurica J; Kyr M; McCaskey Hadasova E; Tomandl J
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():92-5. PubMed ID: 20027151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of bupropion, metroprolol, midazolam, phenacetin, omeprazole and tolbutamide in rat plasma by UPLC-MS/MS and its application to cytochrome P450 activity study in rats.
    Ma J; Wang S; Zhang M; Zhang Q; Zhou Y; Lin C; Lin G; Wang X
    Biomed Chromatogr; 2015 Aug; 29(8):1203-12. PubMed ID: 25582505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of an HPLC Method for the Simultaneous Quantification of Metabolic Reaction Products Catalysed by CYP2C11 Enzymes in Rat Liver Microsomes: In Vitro Inhibitory Effect of Salicylic Acid on CYP2C11 Enzyme.
    Salhab H; Naughton DP; Barker J
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31775347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat.
    Wang X; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2010 Mar; 17(3-4):203-11. PubMed ID: 19679455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Rat CYP1A2 and CYP2C11 by Honokiol, a Component of Traditional Chinese Medicine.
    Li J; Li MR; Sun B; Liu CM; Ren J; Zhi WQ; Zhang PY; Qiao HL; Gao N
    Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):787-796. PubMed ID: 31175627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgo biloba extract modifies hypoglycemic action of tolbutamide via hepatic cytochrome P450 mediated mechanism in aged rats.
    Sugiyama T; Kubota Y; Shinozuka K; Yamada S; Wu J; Umegaki K
    Life Sci; 2004 Jul; 75(9):1113-22. PubMed ID: 15207658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of in vitro and in vivo treatment with mitomycin C on activities of CYP2D1/2, CYP2C11, and CYP1A2 in rat liver.
    Hao FR; Yan MF; Tong SG; Xu LM; Jn YZ
    Yao Xue Xue Bao; 2004 Nov; 39(11):897-903. PubMed ID: 15696929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UPLC-MS-MS method for simultaneous determination of caffeine, tolbutamide, metoprolol, and dapsone in rat plasma and its application to cytochrome P450 activity study in rats.
    Liu Y; Li X; Yang C; Tai S; Zhang X; Liu G
    J Chromatogr Sci; 2013 Jan; 51(1):26-32. PubMed ID: 22695883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an experimental malaria infection on the metabolism of phenacetin in the rat isolated perfused liver.
    Glazier AP; Kokwaro GO; Ismail S; Edwards G
    Xenobiotica; 1994 Aug; 24(8):785-93. PubMed ID: 7839701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple high-performance liquid chromatographic method for the determination of tolbutamide and its metabolites in human plasma and urine using photodiode-array detection.
    Csillag K; Vereczkey L; Gachályi B
    J Chromatogr; 1989 May; 490(2):355-63. PubMed ID: 2768408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.
    Palamanda J; Feng WW; Lin CC; Nomeir AA
    Drug Metab Dispos; 2000 Jan; 28(1):38-43. PubMed ID: 10611138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of effects of chronic hydrogen sulfide poisoning on cytochrome P450 isoforms activity of rats by cocktail approach.
    Wang X; Chen X; Chen M; Hu G; Ma J; Pan J; Hu L; Lin G
    Biol Pharm Bull; 2013; 36(10):1627-33. PubMed ID: 24088256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid determination of five probe drugs and their metabolites in human plasma and urine by liquid chromatography/tandem mass spectrometry: application to cytochrome P450 phenotyping studies.
    Yin OQ; Lam SS; Lo CM; Chow MS
    Rapid Commun Mass Spectrom; 2004; 18(23):2921-33. PubMed ID: 15529418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel cytochrome p450 bioaffinity detection system coupled online to gradient reversed-phase high-performance liquid chromatography.
    Kool J; van Liempd SM; Ramautar R; Schenk T; Meerman JH; Irth H; Commandeur JN; Vermeulen NP
    J Biomol Screen; 2005 Aug; 10(5):427-36. PubMed ID: 16093552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 1999 Dec; 27(12):1519-22. PubMed ID: 10627170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.